Ceftobiprole: Phase III data

In the Phase III STRAUSS II trial in 828 patients with complicated Gram-positive and Gram-negative skin infections, ceftobiprole met the primary

Read the full 211 word article

How to gain access

Continue reading with a
two-week free trial.